Related Experiment Video
Updated: Jul 18, 2026

10:28
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
[Update in Hepatitis C virus associated extrahepatic manifestations]
1Service de Médecine Interne, Hôpital de la Pitié-Salpêtrière, 91, boulevard de l'Hôpital, 75651 Paris cedex 13, France.
Summary
Hepatitis C virus (HCV) infection is linked to various extra-hepatic manifestations (EHM). Current research explores the mechanisms and treatments, including anti-CD20 therapy for conditions like cryoglobulinemia.
Area of Science:
- Hepatology
- Immunology
- Virology
Context:
- Hepatitis C virus (HCV) infection presents numerous extra-hepatic manifestations (EHM).
- Despite extensive research, the precise mechanisms linking HCV to EHM remain incompletely understood.
- EHM associated with HCV continue to be a significant clinical concern over 15 years post-virus discovery.
Purpose:
- To review the primary extra-hepatic manifestations associated with Hepatitis C Virus infection.
- To highlight current areas of interest and ongoing research in HCV-associated EHM.
- To discuss the potential impact of emerging therapies on managing these conditions.
Summary:
- Mixed cryoglobulinemia and its vasculitic complications are frequent HCV-associated EHMs.
- Other notable HCV-EHM include chronic fatigue, sicca syndrome, non-insulin-dependent diabetes mellitus, and B-cell lymphoproliferations.
- HCV-related splenic lymphoma with villous lymphocytes and auto-antibody production are also key areas of focus.
Impact:
- Understanding HCV-EHM mechanisms is crucial for developing targeted therapies.
- Anti-CD20 therapy shows promise for managing cryoglobulinemic vasculitis.
- Further research is vital to elucidate the pathogenesis of these complex conditions.
Related Concept Videos
Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
